...
机译:厄贝沙坦通过抑制2型糖尿病DB / DB小鼠的RANKL-RANK-NF-Kappa B途径来改善糖尿病肾病
Southern Med Univ ZhuJiang Hosp Dept Nephrol Guangzhou 510280 Guangdong Peoples R China;
Southern Med Univ ZhuJiang Hosp Dept Nephrol Guangzhou 510280 Guangdong Peoples R China;
Southern Med Univ ZhuJiang Hosp Dept Gerontol Guangzhou 510280 Guangdong Peoples R China;
Southern Med Univ ZhuJiang Hosp Dept Nephrol Guangzhou 510280 Guangdong Peoples R China;
Southern Med Univ ZhuJiang Hosp Dept Nephrol Guangzhou 510280 Guangdong Peoples R China;
Southern Med Univ ZhuJiang Hosp Dept Nephrol Guangzhou 510280 Guangdong Peoples R China;
Southern Med Univ ZhuJiang Hosp Dept Nephrol Guangzhou 510280 Guangdong Peoples R China;
Southern Med Univ ZhuJiang Hosp Dept Nephrol Guangzhou 510280 Guangdong Peoples R China;
Southern Med Univ ZhuJiang Hosp Dept Emergency Guangzhou 510280 Guangdong Peoples R China;
Southern Med Univ ZhuJiang Hosp Dept Nephrol Guangzhou 510280 Guangdong Peoples R China;
Southern Med Univ ZhuJiang Hosp Dept Nephrol Guangzhou 510280 Guangdong Peoples R China;
机译:厄贝沙坦通过抑制2型糖尿病DB / DB小鼠的RANKL-RANK-NF-Kappa B途径来改善糖尿病肾病
机译:厄贝沙坦通过刺激PPAR-Gamma,AMPK / AKT / MTOR信号传导和自噬改善2型糖尿病DB / DB小鼠中的高脂血症和肝脏脂肪变性
机译:马齿ula的水提物可通过抑制糖尿病db / db小鼠的肾纤维化和炎症改善糖尿病性肾病
机译:基于1H NMR的糖尿病db / db小鼠尿液和血清样品的代谢组学研究
机译:II型糖尿病肾病(T2DN)大鼠的糖尿病肾病的遗传和生理学表征
机译:厄贝沙坦通过抑制2型糖尿病db / db小鼠的RANKL-RANK-NF-κB途径改善糖尿病性肾病